NCT00462787View on ClinicalTrials.gov

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Leukemia
Interventions
BIOLOGICAL

filgrastim

DRUG

clofarabine

DRUG

dexamethasone

DRUG

thiotepa

DRUG

topotecan hydrochloride

DRUG

vinorelbine tartrate

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00462787 - Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia | Biotech Hunter | Biotech Hunter